SHANNON HOGATE: Open Payments
NPI 1518146752 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,417 in 120 payments from 20 companies in 2025. Trend: 2023 $2,159 · 2024 $2,104 · 2025 $2,417
Food & beverage: $2,256Education: $160
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $382 |
| Regeneron Healthcare Solutions, Inc. | 12 | $312 |
| GlaxoSmithKline, LLC. | 15 | $240 |
| BioCryst US Sales Co., LLC | 6 | $222 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $197 |
| CSL Behring | 7 | $182 |
| PFIZER INC. | 18 | $158 |
| ARS Pharmaceuticals Operations, Inc. | 10 | $147 |
| Genentech USA, Inc. | 4 | $105 |
| GENZYME CORPORATION | 3 | $91 |
Products named: DUPIXENT, ORLADEYO, HYQVIA, TRELEGY ELLIPTA, AIRSUPRA, NEFFY, Xolair, FASENRA.
Industry payments across DE — which companies pay providers there.
